Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page
- Check6 days agoChange DetectedThe page shows a minor revision from v3.3.1 to v3.3.2; no study content or eligibility criteria have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page adds a note that PubMed-sourced publications are auto-filled and may not all pertain to the study, and updates the Revision to v3.3.1. The corresponding deletion text clarifies that PubMed publications are auto-created by ClinicalTrials.gov using the NCT number and may not be related.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding status notice about NIH operations. This change affects boilerplate site messaging rather than the study details, eligibility criteria, or results.SummaryDifference0.4%

- Check34 days agoChange DetectedNo substantive changes to the study details were observed between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedCore update: add a government funding status notice and update to v3.2.0; remove the old v3.1.0 tag. The new notice provides critical operational status, making it the primary change.SummaryDifference3%

- Check70 days agoChange DetectedUpdated version to v3.1.0 with new contact details (emails and phone numbers) and removal of the old version v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.